Aigen Investment Management, LP

Position in JNJ — Johnson & Johnson

CIK 1741224 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$914,545

-$69,916 QoQ

Shares Held

3,601

-24.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#3,101

of 4,676 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $6,988,444 across 5 Drug Manufacturers - General names. JNJ ranks #3 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	29,983	$3,788,052
2	LLY	ELI LILLY & Co	1,102	$1,321,771
3	JNJ	Johnson & Johnson This page	3,601	$914,545
4	SNY	Sanofi	14,359	$612,554
5	NVS	Novartis AG	2,243	$351,522

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$914,545	3,601	-24.3%	Shares	Sole	2026-08-14
2025-12-31	$984,461	4,757	-2.6%	Shares	Sole	2026-02-13
2025-09-30	$905,405	4,883	-37.6%	Shares	Sole	2025-11-14
2025-06-30	$1,194,963	7,823	+41.1%	Shares	Sole	2025-08-12
2025-03-31	$919,251	5,543	-4.3%	Shares	Sole	2025-05-12
2024-12-31	$837,783	5,793	-12.2%	Shares	Sole	2025-02-06
2023-12-31	$1,034,013	6,597	+15.2%	Shares	Sole	2024-02-09
2023-09-30	$891,980	5,727	-93.1%	Shares	Sole	2023-11-13
2023-03-31	$12,948,080	83,536	+427.1%	Shares	Sole	2023-05-15
2022-06-30	$2,813,355	15,849	-38.4%	Shares	Sole	2022-08-02
2021-12-31	$4,399,236	25,716	+94.4%	Shares	Sole	2022-02-11
2021-09-30	$2,136,806	13,231	-60.0%	Shares	Sole	2021-11-12
2020-12-31	$5,201,094	33,048	+1675.8%	Shares	Sole	2021-02-12
2020-09-30	$277,065	1,861	-91.8%	Shares	Sole	2020-11-06
2020-06-30	$3,211,004	22,833	—	Shares	Sole	2020-08-10
No filing history on record for this holder in this stock.